Effect of interleukin-17 on the expression of chemokines in gingival epithelial cells

Eur J Oral Sci. 2011 Oct;119(5):339-44. doi: 10.1111/j.1600-0722.2011.00842.x. Epub 2011 Aug 12.

Abstract

The role of interleukin (IL)-17 in cellular communication in inflammation has been well described, and a positive correlation between the severity of periodontitis and the level of IL-17 was reported. Although epithelial cells are a major target of IL-17, little is known about the effect of IL-17 on the production of chemokines by human gingival epithelial cells (HGECs). We evaluated the effects of IL-17 on the expression of CXCL8 and CCL2 by HGECs using quantitative real-time PCR and ELISA. In addition, the role of the nuclear factor (NF)-κB signalling pathway in the IL-17-mediated expression of chemokines was assessed using a specific inhibitor. Stimulation with IL-17 up-regulated the expression of CXCL8 mRNA but not of CCL2 mRNA in HGECs, whereas tumour necrosis factor-α (TNF-α) elevated the expression of mRNA for both chemokines. Stimulation with IL-17 up-regulated the secretion of CXCL8 protein, but not the secretion of CCL2 protein. The effect of IL-17 on CXCL8 production was suppressed using an anti-IL-17R Ig, suggesting a role for a specific receptor-ligand interaction. Inhibition of the NF-κB signalling pathway demonstrated that NF-κB activation is required for the CXCL8 expression in HGECs. In conclusion, IL-17 is involved in the regulation of the innate immune response in HGECs by inducing CXCL8 production.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Cell Line
  • Chemokine CCL2 / drug effects*
  • Enzyme-Linked Immunosorbent Assay
  • Epithelial Cells / drug effects
  • Gingiva / cytology
  • Gingiva / drug effects*
  • Humans
  • Immunity, Innate / immunology
  • Interleukin-17 / pharmacology*
  • Interleukin-8 / drug effects*
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B p50 Subunit / drug effects
  • Nitriles / pharmacology
  • Real-Time Polymerase Chain Reaction
  • Receptors, Interleukin / antagonists & inhibitors
  • Receptors, Interleukin / immunology
  • Receptors, Interleukin-17 / antagonists & inhibitors
  • Receptors, Interleukin-17 / immunology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Sulfones / pharmacology
  • Transcription Factor RelA / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Antibodies, Monoclonal
  • CCL2 protein, human
  • CXCL8 protein, human
  • Chemokine CCL2
  • IL17RA protein, human
  • IL17RC protein, human
  • Interleukin-17
  • Interleukin-8
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Nitriles
  • Receptors, Interleukin
  • Receptors, Interleukin-17
  • Sulfones
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha